A 58-year-old man from Delhi presents with painless jaundice, pale stools, and dark urine for 3 weeks. Abdominal examination reveals a palpable gallbladder. Serum bilirubin is 8.2 mg/dL (direct 6.8 mg/dL), and CA 19-9 is elevated at 180 U/mL. Transabdominal ultrasound shows a hypoechoic lesion in the pancreatic head with dilated intrahepatic bile ducts and a dilated common bile duct (12 mm). What is the most appropriate next step in management?

Explanation

## Clinical Context This patient presents with **obstructive jaundice** secondary to a suspected **pancreatic head cancer** (painless jaundice + palpable gallbladder [Courvoisier sign] + elevated CA 19-9). While biliary drainage is eventually needed, the **immediate priority is staging** to determine operability and guide treatment strategy. ## Why Contrast-Enhanced CT is the Next Step **Key Point:** Before any intervention (surgical or endoscopic), **staging with contrast-enhanced CT (CECT) abdomen and pelvis is mandatory** in suspected pancreatic cancer. This determines: - Resectability (local extension, vascular involvement) - Metastatic disease (liver, peritoneum, distant nodes) - Operability and treatment intent (curative vs. palliative) **High-Yield:** The TNM staging and assessment of vascular involvement (superior mesenteric vein/artery, portal vein encasement) on CECT dictates whether the patient is a candidate for curative resection or requires palliative bypass/drainage. ## Management Algorithm ```mermaid flowchart TD A[Suspected pancreatic head cancer + obstructive jaundice]:::outcome --> B[CECT abdomen/pelvis for staging]:::action B --> C{Resectable?}:::decision C -->|Yes| D[Proceed to curative Whipple]:::action C -->|No, locally advanced| E[Neoadjuvant chemotherapy ± radiation]:::action C -->|Metastatic| F[Palliative chemotherapy + biliary drainage]:::action D --> G[Preoperative biliary drainage if needed]:::action E --> H[Restage after neoadjuvant]:::action F --> I[ERCP/PTC for drainage]:::action ``` **Clinical Pearl:** Preoperative biliary drainage (ERCP stent) is **not routinely indicated** in resectable pancreatic cancer unless there is severe cholangitis, renal dysfunction, or prolonged delay to surgery. Staging must come first. ## Why Other Options Are Premature | Option | Why Not First | Timing | |--------|---------------|--------| | ERCP with stent | Addresses symptom (jaundice) but does not guide treatment strategy; premature without staging | After staging if unresectable | | Immediate Whipple | Assumes resectability without imaging proof; high morbidity if metastatic disease present | After staging confirms resectability | | PTC with external drain | Indicated only if ERCP fails or patient has altered anatomy; not first-line for obstructive jaundice | Rescue option | **Mnemonic:** **STAGE before GATE** — Stage the cancer (CECT) before opening any gates (surgery or endoscopy).